Entrada Therapeutics, Inc. (TRDA)
6.56
-0.55
(-7.74%)
USD |
NASDAQ |
Sep 10, 12:28
Entrada Therapeutics Market Cap : 255.42M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 276.84M |
| September 08, 2026 | 292.80M |
| September 04, 2026 | 277.62M |
| September 03, 2026 | 279.18M |
| September 02, 2026 | 284.24M |
| September 01, 2026 | 275.28M |
| August 31, 2026 | 274.50M |
| August 28, 2026 | 272.56M |
| August 27, 2026 | 283.07M |
| August 26, 2026 | 272.56M |
| August 25, 2026 | 296.70M |
| August 24, 2026 | 285.41M |
| August 21, 2026 | 294.75M |
| August 20, 2026 | 295.92M |
| August 19, 2026 | 302.93M |
| August 18, 2026 | 283.07M |
| August 17, 2026 | 285.02M |
| August 14, 2026 | 290.47M |
| August 13, 2026 | 290.08M |
| August 12, 2026 | 298.64M |
| August 11, 2026 | 274.11M |
| August 10, 2026 | 270.61M |
| August 07, 2026 | 267.50M |
| August 06, 2026 | 267.50M |
| August 05, 2026 | 274.89M |
| Date | Value |
|---|---|
| August 04, 2026 | 281.90M |
| August 03, 2026 | 282.68M |
| July 31, 2026 | 263.59M |
| July 30, 2026 | 262.82M |
| July 29, 2026 | 254.27M |
| July 28, 2026 | 226.32M |
| July 27, 2026 | 236.03M |
| July 24, 2026 | 227.10M |
| July 23, 2026 | 234.86M |
| July 22, 2026 | 238.75M |
| July 21, 2026 | 250.78M |
| July 20, 2026 | 246.12M |
| July 17, 2026 | 267.47M |
| July 16, 2026 | 266.70M |
| July 15, 2026 | 276.01M |
| July 14, 2026 | 263.98M |
| July 13, 2026 | 256.22M |
| July 10, 2026 | 268.64M |
| July 09, 2026 | 287.27M |
| July 08, 2026 | 284.17M |
| July 07, 2026 | 289.21M |
| July 06, 2026 | 292.32M |
| July 02, 2026 | 299.70M |
| July 01, 2026 | 294.65M |
| June 30, 2026 | 285.72M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.64B |
| Oncolytics Biotech, Inc. | 98.41M |
| Sangamo Therapeutics, Inc. | 64.21M |
| Sarepta Therapeutics, Inc. | 2.162B |
| Anixa Biosciences, Inc. | 91.59M |
Market Cap Related Metrics
| PS Ratio | 58.49 |
| PEG Ratio | -0.0135 |
| Price to Book Value | 1.094 |
| Price | 6.56 |
| Earnings Yield | -60.49% |
| PEGY Ratio | -0.0135 |